Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia

Some cytokines have been involved in the pathogenesis of late onset Alzheimer’s disease (LOAD). A possible increase in plasma cytokines levels has been reported in LOAD and vascular dementia (VD), but the results of previous studies are conflicting. We evaluated the plasma levels of IL-6, TNF-α, IL-...

Full description

Saved in:
Bibliographic Details
Published inJournal of psychiatric research Vol. 41; no. 8; pp. 686 - 693
Main Authors Zuliani, G., Ranzini, M., Guerra, G., Rossi, L., Munari, M.R., Zurlo, A., Volpato, S., Atti, A.R., Blè, A., Fellin, R.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.10.2007
Elsevier
Subjects
Online AccessGet full text
ISSN0022-3956
1879-1379
DOI10.1016/j.jpsychires.2006.02.008

Cover

Abstract Some cytokines have been involved in the pathogenesis of late onset Alzheimer’s disease (LOAD). A possible increase in plasma cytokines levels has been reported in LOAD and vascular dementia (VD), but the results of previous studies are conflicting. We evaluated the plasma levels of IL-6, TNF-α, IL-1β, and IL-10 in four groups of older individuals: 60 patients with LOAD, 80 patients with VD, 40 subjects with cerebrovascular disease but without dementia (CDND), and 42 controls (C). By analysis of covariance (adjustment for age, gender, coronary heart disease, diabetes, hypertension, smoking, and alcohol consumption) we found that: • IL-1β was higher in VD, LOAD, and CDND compared with controls ( p < 0.005). • TNF-α was higher in VD and LOAD compared to C ( p < 0.05), and in VD compared to LOAD ( p < 0.03). • IL-6 was higher in VD compared with LOAD ( p < 0.03). No differences in IL-10 values were found (Kruskal–Wallis, Asymp. Sig. 0.14). By logistic regression analysis, we demonstrated that high levels (defined as above the median) of IL-1β and TNF-α, but not of IL-6, were associated with increased likelihood of having VD and LOAD compared to C, while high IL-6 levels were associated with a increased probability of having VD, compared with LOAD. Our study support the notion of a low-grade systemic inflammation in older patients with LOAD or VD, characterized by an increase in plasma IL-1β and TNF-α levels. The high IL-6 levels found in VD might be not a specific finding, as it might come from several conditions including atherosclerosis and related vascular risk factors, comorbidity, and frailty.
AbstractList Abstract Some cytokines have been involved in the pathogenesis of late onset Alzheimer’s disease (LOAD). A possible increase in plasma cytokines levels has been reported in LOAD and vascular dementia (VD), but the results of previous studies are conflicting. We evaluated the plasma levels of IL-6, TNF-α, IL-1β, and IL-10 in four groups of older individuals: 60 patients with LOAD, 80 patients with VD, 40 subjects with cerebrovascular disease but without dementia (CDND), and 42 controls (C). By analysis of covariance (adjustment for age, gender, coronary heart disease, diabetes, hypertension, smoking, and alcohol consumption) we found that: • IL-1β was higher in VD, LOAD, and CDND compared with controls ( p < 0.005). • TNF-α was higher in VD and LOAD compared to C ( p < 0.05), and in VD compared to LOAD ( p < 0.03). • IL-6 was higher in VD compared with LOAD ( p < 0.03). No differences in IL-10 values were found (Kruskal–Wallis, Asymp. Sig. 0.14). By logistic regression analysis, we demonstrated that high levels (defined as above the median) of IL-1β and TNF-α, but not of IL-6, were associated with increased likelihood of having VD and LOAD compared to C, while high IL-6 levels were associated with a increased probability of having VD, compared with LOAD. Our study support the notion of a low-grade systemic inflammation in older patients with LOAD or VD, characterized by an increase in plasma IL-1β and TNF-α levels. The high IL-6 levels found in VD might be not a specific finding, as it might come from several conditions including atherosclerosis and related vascular risk factors, comorbidity, and frailty.
Some cytokines have been involved in the pathogenesis of late onset Alzheimer’s disease (LOAD). A possible increase in plasma cytokines levels has been reported in LOAD and vascular dementia (VD), but the results of previous studies are conflicting. We evaluated the plasma levels of IL-6, TNF-α, IL-1β, and IL-10 in four groups of older individuals: 60 patients with LOAD, 80 patients with VD, 40 subjects with cerebrovascular disease but without dementia (CDND), and 42 controls (C). By analysis of covariance (adjustment for age, gender, coronary heart disease, diabetes, hypertension, smoking, and alcohol consumption) we found that: • IL-1β was higher in VD, LOAD, and CDND compared with controls ( p < 0.005). • TNF-α was higher in VD and LOAD compared to C ( p < 0.05), and in VD compared to LOAD ( p < 0.03). • IL-6 was higher in VD compared with LOAD ( p < 0.03). No differences in IL-10 values were found (Kruskal–Wallis, Asymp. Sig. 0.14). By logistic regression analysis, we demonstrated that high levels (defined as above the median) of IL-1β and TNF-α, but not of IL-6, were associated with increased likelihood of having VD and LOAD compared to C, while high IL-6 levels were associated with a increased probability of having VD, compared with LOAD. Our study support the notion of a low-grade systemic inflammation in older patients with LOAD or VD, characterized by an increase in plasma IL-1β and TNF-α levels. The high IL-6 levels found in VD might be not a specific finding, as it might come from several conditions including atherosclerosis and related vascular risk factors, comorbidity, and frailty.
Some cytokines have been involved in the pathogenesis of late onset Alzheimer's disease (LOAD). A possible increase in plasma cytokines levels has been reported in LOAD and vascular dementia (VD), but the results of previous studies are conflicting. We evaluated the plasma levels of IL-6, TNF-alpha, IL-1beta, and IL-10 in four groups of older individuals: 60 patients with LOAD, 80 patients with VD, 40 subjects with cerebrovascular disease but without dementia (CDND), and 42 controls (C). By analysis of covariance (adjustment for age, gender, coronary heart disease, diabetes, hypertension, smoking, and alcohol consumption) we found that: *IL-1beta was higher in VD, LOAD, and CDND compared with controls (p<0.005). *TNF-alpha was higher in VD and LOAD compared to C (p<0.05), and in VD compared to LOAD (p<0.03). *IL-6 was higher in VD compared with LOAD (p<0.03). No differences in IL-10 values were found (Kruskal-Wallis, Asymp. Sig. 0.14). By logistic regression analysis, we demonstrated that high levels (defined as above the median) of IL-1beta and TNF-alpha, but not of IL-6, were associated with increased likelihood of having VD and LOAD compared to C, while high IL-6 levels were associated with a increased probability of having VD, compared with LOAD. Our study support the notion of a low-grade systemic inflammation in older patients with LOAD or VD, characterized by an increase in plasma IL-1beta and TNF-alpha levels. The high IL-6 levels found in VD might be not a specific finding, as it might come from several conditions including atherosclerosis and related vascular risk factors, comorbidity, and frailty.Some cytokines have been involved in the pathogenesis of late onset Alzheimer's disease (LOAD). A possible increase in plasma cytokines levels has been reported in LOAD and vascular dementia (VD), but the results of previous studies are conflicting. We evaluated the plasma levels of IL-6, TNF-alpha, IL-1beta, and IL-10 in four groups of older individuals: 60 patients with LOAD, 80 patients with VD, 40 subjects with cerebrovascular disease but without dementia (CDND), and 42 controls (C). By analysis of covariance (adjustment for age, gender, coronary heart disease, diabetes, hypertension, smoking, and alcohol consumption) we found that: *IL-1beta was higher in VD, LOAD, and CDND compared with controls (p<0.005). *TNF-alpha was higher in VD and LOAD compared to C (p<0.05), and in VD compared to LOAD (p<0.03). *IL-6 was higher in VD compared with LOAD (p<0.03). No differences in IL-10 values were found (Kruskal-Wallis, Asymp. Sig. 0.14). By logistic regression analysis, we demonstrated that high levels (defined as above the median) of IL-1beta and TNF-alpha, but not of IL-6, were associated with increased likelihood of having VD and LOAD compared to C, while high IL-6 levels were associated with a increased probability of having VD, compared with LOAD. Our study support the notion of a low-grade systemic inflammation in older patients with LOAD or VD, characterized by an increase in plasma IL-1beta and TNF-alpha levels. The high IL-6 levels found in VD might be not a specific finding, as it might come from several conditions including atherosclerosis and related vascular risk factors, comorbidity, and frailty.
Some cytokines have been involved in the pathogenesis of late onset Alzheimer's disease (LOAD). A possible increase in plasma cytokines levels has been reported in LOAD and vascular dementia (VD), but the results of previous studies are conflicting. We evaluated the plasma levels of IL-6, TNF-alpha, IL-1beta, and IL-10 in four groups of older individuals: 60 patients with LOAD, 80 patients with VD, 40 subjects with cerebrovascular disease but without dementia (CDND), and 42 controls (C). By analysis of covariance (adjustment for age, gender, coronary heart disease, diabetes, hypertension, smoking, and alcohol consumption) we found that: *IL-1beta was higher in VD, LOAD, and CDND compared with controls (p<0.005). *TNF-alpha was higher in VD and LOAD compared to C (p<0.05), and in VD compared to LOAD (p<0.03). *IL-6 was higher in VD compared with LOAD (p<0.03). No differences in IL-10 values were found (Kruskal-Wallis, Asymp. Sig. 0.14). By logistic regression analysis, we demonstrated that high levels (defined as above the median) of IL-1beta and TNF-alpha, but not of IL-6, were associated with increased likelihood of having VD and LOAD compared to C, while high IL-6 levels were associated with a increased probability of having VD, compared with LOAD. Our study support the notion of a low-grade systemic inflammation in older patients with LOAD or VD, characterized by an increase in plasma IL-1beta and TNF-alpha levels. The high IL-6 levels found in VD might be not a specific finding, as it might come from several conditions including atherosclerosis and related vascular risk factors, comorbidity, and frailty.
Some cytokines have been involved in the pathogenesis of late onset Alzheimer's disease (LOAD). A possible increase in plasma cytokines levels has been reported in LOAD and vascular dementia (VD), but the results of previous studies are conflicting. We evaluated the plasma levels of IL-6, TNF-D-alpha, IL-1-D-beta, and IL-10 in four groups of older individuals: 60 patients with LOAD, 80 patients with VD, 40 subjects with cerebrovascular disease but without dementia (CDND), and 42 controls (C). By analysis of covariance (adjustment for age, gender, coronary heart disease, diabetes, hypertension, smoking, and alcohol consumption) we found that: - IL-1-D-beta was higher in VD, LOAD, and CDND compared with controls (p<0.005). - TNF-D-alpha was higher in VD and LOAD compared to C (p<0.05), and in VD compared to LOAD (p<0.03). - IL-6 was higher in VD compared with LOAD (p<0.03). No differences in IL-10 values were found (Kruskal-Wallis, Asymp. Sig. 0.14). By logistic regression analysis, we demonstrated that high levels (defined as above the median) of IL-1-D-beta and TNF-D-alpha, but not of IL-6, were associated with increased likelihood of having VD and LOAD compared to C, while high IL-6 levels were associated with a increased probability of having VD, compared with LOAD. Our study support the notion of a low-grade systemic inflammation in older patients with LOAD or VD, characterized by an increase in plasma IL-1-D-beta and TNF-D-alpha levels. The high IL-6 levels found in VD might be not a specific finding, as it might come from several conditions including atherosclerosis and related vascular risk factors, comorbidity, and frailty. [Copyright 2006 Elsevier Ltd.]
Author Zuliani, G.
Atti, A.R.
Fellin, R.
Zurlo, A.
Munari, M.R.
Guerra, G.
Volpato, S.
Ranzini, M.
Rossi, L.
Blè, A.
Author_xml – sequence: 1
  givenname: G.
  surname: Zuliani
  fullname: Zuliani, G.
  email: gzuliani@hotmail.com
  organization: Department of Clinical and Experimental Medicine, Section of Internal Medicine, Gerontology and Geriatrics, University of Ferrara, via Savonarola No. 9, 44100 Ferrara, FE, Italy
– sequence: 2
  givenname: M.
  surname: Ranzini
  fullname: Ranzini, M.
  organization: Department of Clinical and Experimental Medicine, Section of Internal Medicine, Gerontology and Geriatrics, University of Ferrara, via Savonarola No. 9, 44100 Ferrara, FE, Italy
– sequence: 3
  givenname: G.
  surname: Guerra
  fullname: Guerra, G.
  organization: Department of Clinical and Experimental Medicine, Section of Internal Medicine, Gerontology and Geriatrics, University of Ferrara, via Savonarola No. 9, 44100 Ferrara, FE, Italy
– sequence: 4
  givenname: L.
  surname: Rossi
  fullname: Rossi, L.
  organization: Department of Clinical and Experimental Medicine, Section of Internal Medicine, Gerontology and Geriatrics, University of Ferrara, via Savonarola No. 9, 44100 Ferrara, FE, Italy
– sequence: 5
  givenname: M.R.
  surname: Munari
  fullname: Munari, M.R.
  organization: Long Term Division, Ca’ Foncello Hospital, Treviso, Italy
– sequence: 6
  givenname: A.
  surname: Zurlo
  fullname: Zurlo, A.
  organization: Geriatric Division, S. Anna Hospital, Ferrara, Italy
– sequence: 7
  givenname: S.
  surname: Volpato
  fullname: Volpato, S.
  organization: Department of Clinical and Experimental Medicine, Section of Internal Medicine, Gerontology and Geriatrics, University of Ferrara, via Savonarola No. 9, 44100 Ferrara, FE, Italy
– sequence: 8
  givenname: A.R.
  surname: Atti
  fullname: Atti, A.R.
  organization: Department of Clinical and Experimental Medicine, Section of Internal Medicine, Gerontology and Geriatrics, University of Ferrara, via Savonarola No. 9, 44100 Ferrara, FE, Italy
– sequence: 9
  givenname: A.
  surname: Blè
  fullname: Blè, A.
  organization: Department of Clinical and Experimental Medicine, Section of Internal Medicine, Gerontology and Geriatrics, University of Ferrara, via Savonarola No. 9, 44100 Ferrara, FE, Italy
– sequence: 10
  givenname: R.
  surname: Fellin
  fullname: Fellin, R.
  organization: Department of Clinical and Experimental Medicine, Section of Internal Medicine, Gerontology and Geriatrics, University of Ferrara, via Savonarola No. 9, 44100 Ferrara, FE, Italy
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18688228$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16600299$$D View this record in MEDLINE/PubMed
BookMark eNqNks9u1DAQxiNURLeFV0C-wG2D7cSOc6loK_5JlUACzpbXmWidOs7icYqWE6_B6_EkeLULlSqh9uTD_L7PM_PNSXEUpgBFQRgtGWXy1VAOG9zatYuAJadUlpSXlKpHxYKppl2yqmmPigWlnC-rVsjj4gRxoJQ2nNVPimMmZa617aKAT97gaIjdpunaBUCyiVPvPBAXyOQ7iATn1QA2Ifnu0pp4k4BMASGRc_9jDW6E-PvnLySdQzCYa5HcGLSzN5F0MEJIzjwtHvfGIzw7vKfF17dvvly-X159fPfh8vxqaUUt0pI1shXCMJPbVwo6JXsQFYVKcqU6Ljopeln3q6Zq6tbIlYVadVXX1qyWKuuq0-Ll3jcP8W0GTHp0aMF7E2CaUTe0qplk8l5QNJxL1tQZfH4A59UInd5EN5q41X83mIEXByAPbXwfTbAObzklleJcZe5sz9k4IUbotXXJJDeFFI3zmlG9i1YP-jZavYtWU65ztNlA3TH498f90ou9FPLubxxEjdZBsNBl1CbdTe4hJmd3TKx3weWZr2ELOExzDDlbzTRmgf68O77d7dG8KCq4yAav_2_wsB7-AJgv8Kg
CODEN JPYRA3
CitedBy_id crossref_primary_10_1620_tjem_237_57
crossref_primary_10_1016_j_jns_2008_05_020
crossref_primary_10_1136_jim_2015_000017
crossref_primary_10_3389_fphys_2018_00858
crossref_primary_10_1007_s12031_013_0063_z
crossref_primary_10_1016_j_bbadis_2011_07_004
crossref_primary_10_1016_j_nlm_2016_03_022
crossref_primary_10_1007_s11011_019_00512_2
crossref_primary_10_3390_biomedicines10061448
crossref_primary_10_1093_gerona_glt021
crossref_primary_10_1016_j_arr_2024_102250
crossref_primary_10_1523_JNEUROSCI_2451_17_2018
crossref_primary_10_1155_2013_824120
crossref_primary_10_1159_000446275
crossref_primary_10_1016_j_cyto_2011_11_006
crossref_primary_10_1159_000493142
crossref_primary_10_1515_cclm_2014_0803
crossref_primary_10_1016_j_bbacli_2015_11_004
crossref_primary_10_1016_j_metabol_2024_155941
crossref_primary_10_1016_j_biopsych_2010_06_012
crossref_primary_10_1016_j_phrs_2012_06_006
crossref_primary_10_1111_cns_12632
crossref_primary_10_3233_JAD_150837
crossref_primary_10_1111_jgs_13431
crossref_primary_10_1111_jnc_13240
crossref_primary_10_1007_s11011_014_9551_2
crossref_primary_10_1097_YCO_0b013e3283130fb7
crossref_primary_10_1093_gerona_glq026
crossref_primary_10_1016_j_physbeh_2020_113019
crossref_primary_10_1016_j_nbd_2020_104946
crossref_primary_10_1016_j_jalz_2008_10_004
crossref_primary_10_1371_journal_pone_0033276
crossref_primary_10_1111_jnc_15788
crossref_primary_10_1586_ern_10_52
crossref_primary_10_3389_fimmu_2017_00211
crossref_primary_10_3389_fnagi_2023_1069439
crossref_primary_10_1038_s41598_021_83601_6
crossref_primary_10_1016_j_neurobiolaging_2015_12_002
crossref_primary_10_1371_journal_pone_0193867
crossref_primary_10_1186_s12974_019_1554_9
crossref_primary_10_3389_fnagi_2023_1180913
crossref_primary_10_1007_s11357_011_9301_x
crossref_primary_10_1016_j_jpsychires_2007_03_003
crossref_primary_10_1096_fj_201700431R
crossref_primary_10_1016_j_neurobiolaging_2008_10_012
crossref_primary_10_1016_j_jpsychires_2007_01_004
crossref_primary_10_54097_hset_v36i_5682
crossref_primary_10_1093_cvr_cvp088
crossref_primary_10_1016_j_jns_2021_117537
crossref_primary_10_1111_j_1582_4934_2009_00962_x
crossref_primary_10_1111_j_1532_5415_2008_02055_x
crossref_primary_10_3389_fpsyt_2024_1360623
crossref_primary_10_1016_j_joen_2013_06_014
crossref_primary_10_1159_000530208
crossref_primary_10_3389_fimmu_2021_783882
crossref_primary_10_1038_s41380_020_00971_5
crossref_primary_10_5551_jat_E608
crossref_primary_10_1080_00207454_2023_2292951
crossref_primary_10_1016_j_xphs_2019_02_016
crossref_primary_10_1016_j_jpsychores_2017_03_010
crossref_primary_10_1186_s40478_023_01590_1
crossref_primary_10_1007_s13238_016_0338_6
crossref_primary_10_1111_odi_14646
crossref_primary_10_18632_aging_103371
crossref_primary_10_5115_acb_2013_46_4_229
crossref_primary_10_1016_j_pneurobio_2009_01_001
crossref_primary_10_1155_2020_8253904
crossref_primary_10_1111_j_1582_4934_2008_00496_x
crossref_primary_10_1016_j_apsb_2022_09_023
crossref_primary_10_2174_1567205019666220120113305
crossref_primary_10_1089_jmf_2015_3512
crossref_primary_10_1517_14712590903136688
crossref_primary_10_1111_jdv_18360
crossref_primary_10_1016_S0033_3182_10_70739_8
crossref_primary_10_1371_journal_pone_0146290
crossref_primary_10_1007_s11357_022_00556_w
crossref_primary_10_1159_000474940
crossref_primary_10_1016_j_clnu_2015_09_004
crossref_primary_10_1016_j_nbd_2022_105799
crossref_primary_10_1007_s00011_009_0113_8
crossref_primary_10_1186_s13024_021_00506_8
crossref_primary_10_36150_2499_6564_N382
crossref_primary_10_3390_ijms18122633
crossref_primary_10_1007_s10072_020_04594_0
crossref_primary_10_1007_s10571_021_01078_3
crossref_primary_10_3233_JAD_215090
crossref_primary_10_1007_s11357_018_0010_6
crossref_primary_10_1507_endocrj_K09E_046
crossref_primary_10_1159_000488318
crossref_primary_10_3892_mmr_2013_1573
crossref_primary_10_1016_j_alcohol_2022_08_013
crossref_primary_10_1002_alz_12651
crossref_primary_10_1007_s11357_024_01294_x
crossref_primary_10_1186_s12877_025_05800_4
crossref_primary_10_1007_s00277_016_2709_8
crossref_primary_10_1016_j_bbi_2016_09_024
crossref_primary_10_1016_j_brainres_2024_148821
crossref_primary_10_1007_s11011_023_01188_5
crossref_primary_10_1016_j_neuroscience_2018_03_016
crossref_primary_10_1016_j_ajp_2017_04_015
crossref_primary_10_1016_j_jagp_2022_11_009
crossref_primary_10_1038_s41598_018_30487_6
crossref_primary_10_4103_ORCL_ORCL_4_24
crossref_primary_10_1111_ejn_15207
crossref_primary_10_2174_1381612826666200114105515
crossref_primary_10_30565_medalanya_1422120
crossref_primary_10_1007_s12031_018_1189_9
crossref_primary_10_1155_2022_8099459
crossref_primary_10_1007_s11011_021_00890_6
crossref_primary_10_1016_j_jneuroim_2007_10_020
crossref_primary_10_1016_j_bbagen_2012_11_019
crossref_primary_10_1016_j_smim_2022_101600
crossref_primary_10_1186_1471_2377_11_121
crossref_primary_10_1016_j_cca_2017_11_009
crossref_primary_10_1210_endrev_bnad029
crossref_primary_10_1186_s40168_023_01567_1
crossref_primary_10_14336_AD_2023_0926_1
crossref_primary_10_1155_2024_6640130
crossref_primary_10_1007_s11033_023_08438_w
crossref_primary_10_1155_2013_145345
crossref_primary_10_1371_journal_pone_0081911
crossref_primary_10_1080_07391102_2023_2256409
crossref_primary_10_1016_j_neubiorev_2010_09_010
crossref_primary_10_3390_antiox12030597
crossref_primary_10_1002_gps_4238
crossref_primary_10_1111_jgs_13165
crossref_primary_10_1038_srep37486
crossref_primary_10_1007_s12017_012_8201_2
crossref_primary_10_1007_s11064_006_9125_8
crossref_primary_10_1111_j_1532_5415_2008_02136_x
crossref_primary_10_1016_j_nbd_2006_11_011
crossref_primary_10_1159_000519885
crossref_primary_10_1111_j_1365_2990_2012_01307_x
crossref_primary_10_1177_147323001204000322
crossref_primary_10_1007_s42250_022_00339_y
crossref_primary_10_1155_2014_309507
crossref_primary_10_1016_j_jns_2013_11_041
crossref_primary_10_1186_1472_6882_14_43
crossref_primary_10_1155_2011_649629
crossref_primary_10_1007_s11373_008_9242_2
crossref_primary_10_1186_s12902_019_0402_3
crossref_primary_10_1016_j_neurobiolaging_2017_06_006
crossref_primary_10_1111_j_1755_5949_2011_00245_x
crossref_primary_10_4103_jfmpc_jfmpc_850_19
crossref_primary_10_1007_s11064_012_0750_0
crossref_primary_10_1016_j_neuint_2024_105763
crossref_primary_10_1021_cr200472g
crossref_primary_10_1371_journal_pone_0274503
crossref_primary_10_1002_elps_201200161
crossref_primary_10_1016_j_neuroscience_2015_05_052
crossref_primary_10_1002_gps_1923
crossref_primary_10_1016_j_neuropharm_2022_109023
crossref_primary_10_1097_TEN_0b013e3181c0526f
crossref_primary_10_2174_1381612828666220408124809
crossref_primary_10_1007_s41999_019_00214_z
crossref_primary_10_1111_ggi_12783
crossref_primary_10_1016_j_exger_2014_10_009
crossref_primary_10_5812_jjm_30444
crossref_primary_10_1007_s00784_015_1646_6
crossref_primary_10_1016_j_arr_2016_09_007
Cites_doi 10.1016/S0165-5728(97)00204-X
10.1016/0304-3940(90)90666-W
10.1016/S0022-3956(97)00023-X
10.1016/S0361-9230(03)00088-1
10.1016/0022-510X(95)00016-U
10.1212/WNL.34.7.939
10.1111/j.1749-6632.2000.tb05399.x
10.1212/01.WNL.0000149519.47454.F2
10.1161/01.CIR.0000109503.13955.00
10.1002/ana.10265
10.1093/gerona/59.9.M924
10.2165/00002512-200320020-00002
10.2174/1389450043345308
10.1016/S0140-6736(96)09328-2
10.1016/S0531-5565(01)00191-7
10.1016/S0047-6374(01)00313-X
10.1093/gerona/54.7.M357
10.1136/bmj.310.6985.970
10.1212/01.WNL.0000073620.42047.D7
10.1161/01.ATV.0000040224.49362.60
10.1016/j.exger.2004.01.009
10.1161/01.CIR.101.15.1767
10.1161/01.STR.0000158915.28329.51
10.1113/jphysiol.2002.022285
10.1006/nbdi.2002.0556
10.1093/gerona/52A.4.M201
10.1161/01.ATV.20.10.2255
10.1093/oxfordjournals.aje.a009106
10.1111/j.1600-0404.2005.00416.x
10.1111/j.1600-0404.2004.00286.x
10.1161/01.ATV.0000079512.66448.1D
10.1073/pnas.86.19.7611
10.1073/pnas.86.19.7606
10.1097/00002093-199809000-00016
10.1212/WNL.43.2.250
10.1016/S0304-3940(98)00136-0
10.1016/S0002-9343(99)00066-2
10.1016/S0165-5728(99)00226-X
10.1038/sj.cdd.4401143
10.1212/WNL.41.12.1886
10.1016/S0049-0172(95)80020-4
10.1016/S0022-3956(99)00016-3
10.1016/S1474-4422(05)70141-1
10.1016/S0022-3565(24)29260-0
10.1016/S0889-1591(02)00004-1
10.1016/j.atherosclerosis.2004.11.026
ContentType Journal Article
Copyright 2006 Elsevier Ltd
Elsevier Ltd
2007 INIST-CNRS
Copyright_xml – notice: 2006 Elsevier Ltd
– notice: Elsevier Ltd
– notice: 2007 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7X8
DOI 10.1016/j.jpsychires.2006.02.008
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Applied Social Sciences Index & Abstracts (ASSIA)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Applied Social Sciences Index and Abstracts (ASSIA)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE

Applied Social Sciences Index and Abstracts (ASSIA)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1379
EndPage 693
ExternalDocumentID 16600299
18688228
10_1016_j_jpsychires_2006_02_008
S0022395606000525
1_s2_0_S0022395606000525
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29L
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
9JO
AABNK
AADFP
AAEDT
AAEDW
AAGJA
AAGUQ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABIVO
ABJNI
ABLJU
ABMAC
ABMZM
ABOYX
ABPPZ
ABWVN
ABXDB
ACDAQ
ACGFS
ACHQT
ACIEU
ACIUM
ACNCT
ACRLP
ACRPL
ACVFH
ACXNI
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADXHL
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEG
HF~
HMK
HMO
HMQ
HMW
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M29
M2V
M39
M3V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OH0
OKEIE
OU-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SPS
SSB
SSH
SSN
SSY
SSZ
T5K
WUQ
YQT
Z5R
ZGI
~G-
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
PKN
RIG
AADPK
AAIAV
ABLVK
ABYKQ
AFYLN
AJBFU
EFLBG
LCYCR
ZA5
AAYXX
ACLOT
CITATION
~HD
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QJ
7X8
ID FETCH-LOGICAL-c545t-176955a1a37988ed86fe530e36288d25d65f64fb73749a6bce48d3d9414685a13
IEDL.DBID .~1
ISSN 0022-3956
IngestDate Sun Sep 28 12:05:20 EDT 2025
Sun Sep 28 04:06:24 EDT 2025
Wed Feb 19 01:49:02 EST 2025
Thu Feb 13 05:29:45 EST 2025
Thu Apr 24 22:57:53 EDT 2025
Wed Oct 01 01:47:01 EDT 2025
Fri Feb 23 02:28:04 EST 2024
Sun Feb 23 10:18:43 EST 2025
Tue Aug 26 18:34:03 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords Vascular dementia
TNF-α
Alzheimer’s disease
IL-1β
IL-6
Plasma citokynes
Human
Nervous system diseases
Late
Alzheimer disease
Cytokine
Cardiovascular disease
Interleukin 1β
Cerebral disorder
Interleukin 6
Vascular disease
Age of onset
Central nervous system disease
Degenerative disease
Alzheimer's disease
Cerebrovascular disease
Tumor necrosis factor α
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c545t-176955a1a37988ed86fe530e36288d25d65f64fb73749a6bce48d3d9414685a13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 16600299
PQID 57226174
PQPubID 24071
PageCount 8
ParticipantIDs proquest_miscellaneous_70341616
proquest_miscellaneous_57226174
pubmed_primary_16600299
pascalfrancis_primary_18688228
crossref_citationtrail_10_1016_j_jpsychires_2006_02_008
crossref_primary_10_1016_j_jpsychires_2006_02_008
elsevier_sciencedirect_doi_10_1016_j_jpsychires_2006_02_008
elsevier_clinicalkeyesjournals_1_s2_0_S0022395606000525
elsevier_clinicalkey_doi_10_1016_j_jpsychires_2006_02_008
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2007-10-01
PublicationDateYYYYMMDD 2007-10-01
PublicationDate_xml – month: 10
  year: 2007
  text: 2007-10-01
  day: 01
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Journal of psychiatric research
PublicationTitleAlternate J Psychiatr Res
PublicationYear 2007
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Nybo, Nielsen, Pedersen, Moller, Secher (bib32) 2002; 542
Volpato, Pahor, Ferrucci, Simonsick, Guralnik, Kritchevsky (bib46) 2004; 109
Yaffe, Lindquist, Pennix, Simonsick, Pahor, Kritchevsky (bib50) 2003; 61
Harris, Ferrucci, Tracy, Corti, Wacholder, Ettinger (bib14) 1999; 106
Ott, Breteler, Harskamp (bib33) 1995; 310
Hofman, Ott, Breteler, Bots, Slooter, van Harskamp (bib16) 1997; 349
Roman, Tatemichi, Erkinjunnti (bib38) 1993; 43
Griffin, Stanley, Ling (bib13) 1989; 86
Cacquevel, Lebeurrier, Cheenne, Vivien (bib5) 2004; 5
Schmidt, Schmidt, Curb, Masaki, White Lon, Launer (bib39) 2002; 52
Singh, Guthikonda (bib40) 1997; 31
Cohen, Pieper, Harris (bib7) 1997; 52
Ridker, Rifai, Stamper (bib37) 2000; 101
Angelis, Scharf, Mander, Vajda, Christophidis (bib1) 1998; 13
Maes, DeVos, Wauters, Demedts, Maurits, Neels (bib29) 1999; 33
Waje-Andreassen, Krakenes, Ulvestad, Thomassen, Myhr, Aarseth (bib48) 2005; 111
Jazet, Pijl, Meinders (bib20) 2003; 61
Blasko, Grubeck-Loebenstein (bib3) 2003; 20
De Luigi, Fragiacomo, Lucca, Quadri, Tettamanti, De Simoni (bib8) 2001; 122
Licastro, Pedrini, Caputo, Annoni, Davis, Ferri (bib27) 2000; 103
Qiu, Winblad, Fratiglioni (bib36) 2005; 4
Elhajj, Haydar, Hujairi, Goldsmith (bib10) 2004; 52
Pollmacher, Haack, Schuld, Reichenberg, Yirmiya (bib35) 2002; 16
Solerte, Cravello, Ferrari, Fioravanti (bib43) 2000; 917
Jeohn, Kong, Wilson (bib22) 1998; 85
Hoshi, Kitagawa, Yamagami, Furukado, Hougaku, Hori (bib17) 2005; 36
Fratiglioni, Grut, Forsell (bib11) 1991; 41
Goldgaber, Harris, Hla (bib12) 1989; 86
Van Duijn, Hofman, Nagelkerken (bib45) 1990; 22;108
Banks, Farr, La Scola, Morley (bib2) 2001; 299
Lanzrein, Johnston, Perry, Jobst, King, Smith (bib25) 1998; 12
Huang, Erdmann, Peng, Zhao, Zheng (bib18) 2005; 2
Whitmer, Sidney, Selby, Johnston, Yaffe (bib49) 2005; 64
Huberman, Sredni, Stern, Kott, Shalit (bib19) 1995; 130
Jenny, Tracy, Ogg, Luong, Kuller, Arnold (bib21) 2002; 22
Tarkowski, Liljeroth, Minthon, Tarkowski, Wallin, Blennow (bib44) 2003; 61
Wada-Isoe, Wakutani, Urakami, Nakashima (bib47) 2004; 110
Morley, Baumgartner (bib31) 2004
Leibson, Rocca, Hanson, Cha, Kokmen, O’Brien (bib26) 1997; 145
McKhann, Drachman, Folstein, Katzman, Price, Stadlan (bib30) 1984; 34
Krabbe, Pedersen, Bruunsgaard (bib24) 2004; 39
Bruunsgaard, Andersen-Ranberg, Jeune, Pedersen, Skinhoj, Pedersen (bib4) 1999; 54
Sjoholm, Nystrom (bib41) 2005
Kalmijn, Foley, White, Burchfiel, Curb, Petrovitch (bib23) 2000; 20
Cantarella, Uberti, Carsana, Lombardo, Bernardini, Memo (bib6) 2003; 10
Paganelli, Di Iorio, Patricelli, Ripani, Sparvieri, Faricelli (bib34) 2002; 37
Helmersson, Larsson, Vessby, Basu (bib15) 2005; 181
Luc, Bard, Juhan-Vague, Ferrieres, Evans, Amouyel (bib28) 2003; 23
Sjpe (bib42) 1995; 25
De Luigi, Pizzimenti, Quadri, Lucca, Tettamanti, Fragiacomo (bib9) 2002; 11
Licastro (10.1016/j.jpsychires.2006.02.008_bib27) 2000; 103
Singh (10.1016/j.jpsychires.2006.02.008_bib40) 1997; 31
Kalmijn (10.1016/j.jpsychires.2006.02.008_bib23) 2000; 20
Solerte (10.1016/j.jpsychires.2006.02.008_bib43) 2000; 917
Harris (10.1016/j.jpsychires.2006.02.008_bib14) 1999; 106
Goldgaber (10.1016/j.jpsychires.2006.02.008_bib12) 1989; 86
Blasko (10.1016/j.jpsychires.2006.02.008_bib3) 2003; 20
Luc (10.1016/j.jpsychires.2006.02.008_bib28) 2003; 23
Nybo (10.1016/j.jpsychires.2006.02.008_bib32) 2002; 542
Cantarella (10.1016/j.jpsychires.2006.02.008_bib6) 2003; 10
Morley (10.1016/j.jpsychires.2006.02.008_bib31) 2004
Huang (10.1016/j.jpsychires.2006.02.008_bib18) 2005; 2
Tarkowski (10.1016/j.jpsychires.2006.02.008_bib44) 2003; 61
Van Duijn (10.1016/j.jpsychires.2006.02.008_bib45) 1990; 22;108
Roman (10.1016/j.jpsychires.2006.02.008_bib38) 1993; 43
Maes (10.1016/j.jpsychires.2006.02.008_bib29) 1999; 33
Yaffe (10.1016/j.jpsychires.2006.02.008_bib50) 2003; 61
Waje-Andreassen (10.1016/j.jpsychires.2006.02.008_bib48) 2005; 111
Qiu (10.1016/j.jpsychires.2006.02.008_bib36) 2005; 4
Griffin (10.1016/j.jpsychires.2006.02.008_bib13) 1989; 86
Whitmer (10.1016/j.jpsychires.2006.02.008_bib49) 2005; 64
Fratiglioni (10.1016/j.jpsychires.2006.02.008_bib11) 1991; 41
Volpato (10.1016/j.jpsychires.2006.02.008_bib46) 2004; 109
Cacquevel (10.1016/j.jpsychires.2006.02.008_bib5) 2004; 5
Pollmacher (10.1016/j.jpsychires.2006.02.008_bib35) 2002; 16
Angelis (10.1016/j.jpsychires.2006.02.008_bib1) 1998; 13
McKhann (10.1016/j.jpsychires.2006.02.008_bib30) 1984; 34
Wada-Isoe (10.1016/j.jpsychires.2006.02.008_bib47) 2004; 110
Jenny (10.1016/j.jpsychires.2006.02.008_bib21) 2002; 22
Ott (10.1016/j.jpsychires.2006.02.008_bib33) 1995; 310
Jeohn (10.1016/j.jpsychires.2006.02.008_bib22) 1998; 85
Hofman (10.1016/j.jpsychires.2006.02.008_bib16) 1997; 349
Krabbe (10.1016/j.jpsychires.2006.02.008_bib24) 2004; 39
Helmersson (10.1016/j.jpsychires.2006.02.008_bib15) 2005; 181
Lanzrein (10.1016/j.jpsychires.2006.02.008_bib25) 1998; 12
Ridker (10.1016/j.jpsychires.2006.02.008_bib37) 2000; 101
Schmidt (10.1016/j.jpsychires.2006.02.008_bib39) 2002; 52
De Luigi (10.1016/j.jpsychires.2006.02.008_bib8) 2001; 122
Huberman (10.1016/j.jpsychires.2006.02.008_bib19) 1995; 130
Sjpe (10.1016/j.jpsychires.2006.02.008_bib42) 1995; 25
Cohen (10.1016/j.jpsychires.2006.02.008_bib7) 1997; 52
Hoshi (10.1016/j.jpsychires.2006.02.008_bib17) 2005; 36
Jazet (10.1016/j.jpsychires.2006.02.008_bib20) 2003; 61
Banks (10.1016/j.jpsychires.2006.02.008_bib2) 2001; 299
De Luigi (10.1016/j.jpsychires.2006.02.008_bib9) 2002; 11
Leibson (10.1016/j.jpsychires.2006.02.008_bib26) 1997; 145
Elhajj (10.1016/j.jpsychires.2006.02.008_bib10) 2004; 52
Bruunsgaard (10.1016/j.jpsychires.2006.02.008_bib4) 1999; 54
Paganelli (10.1016/j.jpsychires.2006.02.008_bib34) 2002; 37
Sjoholm (10.1016/j.jpsychires.2006.02.008_bib41) 2005
References_xml – volume: 20
  start-page: 2255
  year: 2000
  end-page: 2260
  ident: bib23
  article-title: Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study
  publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology
– volume: 310
  start-page: 970
  year: 1995
  end-page: 973
  ident: bib33
  article-title: Prevalence of Alzheimer disease and vascular dementia: association with education. The Rotterdam Study
  publication-title: British Medical Journal
– volume: 917
  start-page: 331
  year: 2000
  end-page: 340
  ident: bib43
  article-title: Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer’s disease
  publication-title: Annals of the New York Academy of Sciences
– volume: 106
  start-page: 506
  year: 1999
  end-page: 512
  ident: bib14
  article-title: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
  publication-title: The American Journal of Medicine
– volume: 12
  start-page: 215
  year: 1998
  end-page: 227
  ident: bib25
  article-title: Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin
  publication-title: Alzheimer Disease and Associated Disorders
– volume: 101
  start-page: 1767
  year: 2000
  end-page: 1772
  ident: bib37
  article-title: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
  publication-title: Circulation
– volume: 64
  start-page: 277
  year: 2005
  end-page: 281
  ident: bib49
  article-title: Midlife cardiovascular risk factors and risk of dementia in late life
  publication-title: Neurology
– volume: 41
  start-page: 1886
  year: 1991
  end-page: 1892
  ident: bib11
  article-title: Prevalence of Alzheimer disease and other dementias in an elderly urban population: relationship with age, sex and education
  publication-title: Neurology
– volume: 103
  start-page: 97
  year: 2000
  end-page: 102
  ident: bib27
  article-title: Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer’s disease: peripheral inflammation or signals from the brain?
  publication-title: Journal of Neuroimmunology
– volume: 52
  start-page: 96
  year: 2004
  end-page: 102
  ident: bib10
  article-title: The role of inflammation in acute coronary syndromes: review of the literature
  publication-title: The Lebanese Medical Journal
– volume: 54
  start-page: M357
  year: 1999
  end-page: M364
  ident: bib4
  article-title: A high plasma concentration of TNF-α is associated with dementia in centenarians
  publication-title: The Journals of Gerontology Biological Sciences and Medical Sciences
– volume: 130
  start-page: 161
  year: 1995
  end-page: 164
  ident: bib19
  article-title: IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease
  publication-title: Journal of the Neurological Sciences
– volume: 349
  start-page: 151
  year: 1997
  end-page: 154
  ident: bib16
  article-title: Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer disease in the Rotterdam Study
  publication-title: Lancet
– volume: 11
  start-page: 308
  year: 2002
  end-page: 314
  ident: bib9
  article-title: Peripheral inflammatory response in Alzheimer’s disease and multiinfarct dementia
  publication-title: Neurobiology of Disease
– volume: 61
  start-page: 194
  year: 2003
  end-page: 212
  ident: bib20
  article-title: Adipose tissue as an endocrine organ: impact on insulin resistance
  publication-title: The Netherlands Journal of Medicine
– volume: 5
  start-page: 529
  year: 2004
  end-page: 534
  ident: bib5
  article-title: Cytokines in neuroinflammation and Alzheimer’s disease
  publication-title: Current Drug Targets
– volume: 2
  start-page: 113
  year: 2005
  end-page: 122
  ident: bib18
  article-title: The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases
  publication-title: Cell Molecular Immunology
– volume: 61
  start-page: 255
  year: 2003
  end-page: 260
  ident: bib44
  article-title: Cerebral pattern of pro and anti-inflammatory cytokines in dementias
  publication-title: Brain Research Bulletin
– start-page: 924
  year: 2004
  end-page: 929
  ident: bib31
  article-title: Cytokine-related aging process
  publication-title: Journals of Gerontology Series A-Biological Sciences and Medical Sciences
– volume: 43
  start-page: 250
  year: 1993
  end-page: 260
  ident: bib38
  article-title: Vascular dementia: diagnostic criteria for research study
  publication-title: Neurology
– year: 2005
  ident: bib41
  article-title: Inflammation and the etiology of type 2 diabetes
  publication-title: Diabetes/Metabolism Research and Reviews
– volume: 13
  start-page: 106
  year: 1998
  end-page: 108
  ident: bib1
  article-title: Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer’s disease
  publication-title: Neuroscience Letters
– volume: 36
  start-page: 768
  year: 2005
  end-page: 772
  ident: bib17
  article-title: Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction
  publication-title: Stroke
– volume: 61
  start-page: 76
  year: 2003
  end-page: 80
  ident: bib50
  article-title: Inflammatory markers and cognition in well-functioning African-American and white elders
  publication-title: Neurology
– volume: 145
  start-page: 301
  year: 1997
  end-page: 308
  ident: bib26
  article-title: Risk of dementia among persons with diabetes mellitus: a population-based cohort study
  publication-title: American Journal of Epidemiology
– volume: 22
  start-page: 2066
  year: 2002
  end-page: 2071
  ident: bib21
  article-title: In the elderly, interleukin-6 plasma levels and the −174G>C polymorphism are associated with the development of cardiovascular disease
  publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology
– volume: 85
  start-page: 1
  year: 1998
  end-page: 10
  ident: bib22
  article-title: Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures
  publication-title: Journal of Neuroimmunology
– volume: 39
  start-page: 687
  year: 2004
  end-page: 699
  ident: bib24
  article-title: Inflammatory mediators in the elderly
  publication-title: Experimental Gerontology
– volume: 110
  start-page: 124
  year: 2004
  end-page: 127
  ident: bib47
  article-title: Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients
  publication-title: Acta Neurologica Scandinavica
– volume: 299
  start-page: 536
  year: 2001
  end-page: 541
  ident: bib2
  article-title: Intravenous human interleukin 1 impairs memory processing in mice: dependence on blood–brain barrier transport into posterior division of septum
  publication-title: Journal of Pharmacology and Experimental Therapeutics
– volume: 542
  start-page: 991
  year: 2002
  end-page: 995
  ident: bib32
  article-title: Interleukin-6 release from the human brain during prolonged exercise
  publication-title: The Journal of Physiology
– volume: 23
  start-page: 1255
  year: 2003
  end-page: 1261
  ident: bib28
  article-title: C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease. The PRIME Study
  publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology
– volume: 37
  start-page: 257
  year: 2002
  end-page: 263
  ident: bib34
  article-title: Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer’s disease patients
  publication-title: Experimental Gerontology
– volume: 34
  start-page: 939
  year: 1984
  end-page: 944
  ident: bib30
  article-title: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease
  publication-title: Neurology
– volume: 52
  start-page: M201
  year: 1997
  end-page: M208
  ident: bib7
  article-title: The Association of plasma IL-6 levels with functional disability in community-dwelling elderly
  publication-title: Journals of Gerontology Series A-Biological Sciences and Medical Sciences
– volume: 31
  start-page: 657
  year: 1997
  end-page: 660
  ident: bib40
  article-title: Circulating cytokines in Alzheimer’s disease
  publication-title: Journal of Psychiatric Research
– volume: 22;108
  start-page: 350
  year: 1990
  end-page: 354
  ident: bib45
  article-title: Serum levels of interleukin-6 are not elevated in patients with Alzheimer’s disease
  publication-title: Neuroscience Letters
– volume: 20
  start-page: 101
  year: 2003
  end-page: 113
  ident: bib3
  article-title: Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer’s disease
  publication-title: Drugs & Aging
– volume: 33
  start-page: 397
  year: 1999
  end-page: 405
  ident: bib29
  article-title: Inflammatory markers in younger vs. elderly normal volunteers and in patients with Alzheimer’s disease
  publication-title: Journal of Psychiatric Research
– volume: 86
  start-page: 7606
  year: 1989
  end-page: 7610
  ident: bib12
  article-title: Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
– volume: 181
  start-page: 201
  year: 2005
  end-page: 207
  ident: bib15
  article-title: Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men
  publication-title: Atherosclerosis
– volume: 16
  start-page: 525
  year: 2002
  end-page: 532
  ident: bib35
  article-title: Low levels of circulating inflammatory cytokines – Do they affect human brain functions?
  publication-title: Brain, Behavior, and Immunity
– volume: 25
  start-page: 75
  year: 1995
  end-page: 86
  ident: bib42
  article-title: Acute-phase proteins in osteoarthritis
  publication-title: Seminars in Arthritis and Rheumatism
– volume: 111
  start-page: 360
  year: 2005
  end-page: 365
  ident: bib48
  article-title: IL-6: an early marker for outcome in acute ischemic stroke
  publication-title: Acta Neurologica Scandinavica
– volume: 10
  start-page: 134
  year: 2003
  end-page: 141
  ident: bib6
  article-title: Neutralization of TRAIL death pathways protects human neuronal cell line from beta-amyloid toxicity
  publication-title: Cell Death and Differentiation
– volume: 109
  start-page: 607
  year: 2004
  end-page: 612
  ident: bib46
  article-title: Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study
  publication-title: Circulation
– volume: 4
  start-page: 487
  year: 2005
  end-page: 499
  ident: bib36
  article-title: The age-dependent relation of blood pressure to cognitive function and dementia
  publication-title: Lancet Neurology
– volume: 122
  start-page: 1985
  year: 2001
  end-page: 1995
  ident: bib8
  article-title: Inflammatory markers in Alzheimer’s disease and multi-infarct dementia
  publication-title: Mechanism of Ageing and Development
– volume: 86
  start-page: 7611
  year: 1989
  end-page: 7615
  ident: bib13
  article-title: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
– volume: 52
  start-page: 168
  year: 2002
  end-page: 174
  ident: bib39
  article-title: Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study
  publication-title: Annals of Neurology
– volume: 85
  start-page: 1
  year: 1998
  ident: 10.1016/j.jpsychires.2006.02.008_bib22
  article-title: Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures
  publication-title: Journal of Neuroimmunology
  doi: 10.1016/S0165-5728(97)00204-X
– volume: 22;108
  start-page: 350
  issue: 3
  year: 1990
  ident: 10.1016/j.jpsychires.2006.02.008_bib45
  article-title: Serum levels of interleukin-6 are not elevated in patients with Alzheimer’s disease
  publication-title: Neuroscience Letters
  doi: 10.1016/0304-3940(90)90666-W
– volume: 31
  start-page: 657
  issue: 6
  year: 1997
  ident: 10.1016/j.jpsychires.2006.02.008_bib40
  article-title: Circulating cytokines in Alzheimer’s disease
  publication-title: Journal of Psychiatric Research
  doi: 10.1016/S0022-3956(97)00023-X
– volume: 61
  start-page: 255
  year: 2003
  ident: 10.1016/j.jpsychires.2006.02.008_bib44
  article-title: Cerebral pattern of pro and anti-inflammatory cytokines in dementias
  publication-title: Brain Research Bulletin
  doi: 10.1016/S0361-9230(03)00088-1
– volume: 130
  start-page: 161
  year: 1995
  ident: 10.1016/j.jpsychires.2006.02.008_bib19
  article-title: IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease
  publication-title: Journal of the Neurological Sciences
  doi: 10.1016/0022-510X(95)00016-U
– volume: 34
  start-page: 939
  year: 1984
  ident: 10.1016/j.jpsychires.2006.02.008_bib30
  article-title: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease
  publication-title: Neurology
  doi: 10.1212/WNL.34.7.939
– volume: 917
  start-page: 331
  year: 2000
  ident: 10.1016/j.jpsychires.2006.02.008_bib43
  article-title: Overproduction of IFN-gamma and TNF-alpha from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer’s disease
  publication-title: Annals of the New York Academy of Sciences
  doi: 10.1111/j.1749-6632.2000.tb05399.x
– volume: 64
  start-page: 277
  year: 2005
  ident: 10.1016/j.jpsychires.2006.02.008_bib49
  article-title: Midlife cardiovascular risk factors and risk of dementia in late life
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000149519.47454.F2
– volume: 109
  start-page: 607
  issue: 5
  year: 2004
  ident: 10.1016/j.jpsychires.2006.02.008_bib46
  article-title: Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000109503.13955.00
– volume: 52
  start-page: 96
  issue: 2
  year: 2004
  ident: 10.1016/j.jpsychires.2006.02.008_bib10
  article-title: The role of inflammation in acute coronary syndromes: review of the literature
  publication-title: The Lebanese Medical Journal
– volume: 52
  start-page: 168
  year: 2002
  ident: 10.1016/j.jpsychires.2006.02.008_bib39
  article-title: Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study
  publication-title: Annals of Neurology
  doi: 10.1002/ana.10265
– start-page: 924
  year: 2004
  ident: 10.1016/j.jpsychires.2006.02.008_bib31
  article-title: Cytokine-related aging process
  publication-title: Journals of Gerontology Series A-Biological Sciences and Medical Sciences
  doi: 10.1093/gerona/59.9.M924
– volume: 2
  start-page: 113
  year: 2005
  ident: 10.1016/j.jpsychires.2006.02.008_bib18
  article-title: The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases
  publication-title: Cell Molecular Immunology
– volume: 20
  start-page: 101
  issue: 2
  year: 2003
  ident: 10.1016/j.jpsychires.2006.02.008_bib3
  article-title: Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer’s disease
  publication-title: Drugs & Aging
  doi: 10.2165/00002512-200320020-00002
– year: 2005
  ident: 10.1016/j.jpsychires.2006.02.008_bib41
  article-title: Inflammation and the etiology of type 2 diabetes
  publication-title: Diabetes/Metabolism Research and Reviews
– volume: 5
  start-page: 529
  year: 2004
  ident: 10.1016/j.jpsychires.2006.02.008_bib5
  article-title: Cytokines in neuroinflammation and Alzheimer’s disease
  publication-title: Current Drug Targets
  doi: 10.2174/1389450043345308
– volume: 349
  start-page: 151
  year: 1997
  ident: 10.1016/j.jpsychires.2006.02.008_bib16
  article-title: Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer disease in the Rotterdam Study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(96)09328-2
– volume: 37
  start-page: 257
  year: 2002
  ident: 10.1016/j.jpsychires.2006.02.008_bib34
  article-title: Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer’s disease patients
  publication-title: Experimental Gerontology
  doi: 10.1016/S0531-5565(01)00191-7
– volume: 122
  start-page: 1985
  year: 2001
  ident: 10.1016/j.jpsychires.2006.02.008_bib8
  article-title: Inflammatory markers in Alzheimer’s disease and multi-infarct dementia
  publication-title: Mechanism of Ageing and Development
  doi: 10.1016/S0047-6374(01)00313-X
– volume: 54
  start-page: M357
  year: 1999
  ident: 10.1016/j.jpsychires.2006.02.008_bib4
  article-title: A high plasma concentration of TNF-α is associated with dementia in centenarians
  publication-title: The Journals of Gerontology Biological Sciences and Medical Sciences
  doi: 10.1093/gerona/54.7.M357
– volume: 310
  start-page: 970
  year: 1995
  ident: 10.1016/j.jpsychires.2006.02.008_bib33
  article-title: Prevalence of Alzheimer disease and vascular dementia: association with education. The Rotterdam Study
  publication-title: British Medical Journal
  doi: 10.1136/bmj.310.6985.970
– volume: 61
  start-page: 76
  year: 2003
  ident: 10.1016/j.jpsychires.2006.02.008_bib50
  article-title: Inflammatory markers and cognition in well-functioning African-American and white elders
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000073620.42047.D7
– volume: 22
  start-page: 2066
  year: 2002
  ident: 10.1016/j.jpsychires.2006.02.008_bib21
  article-title: In the elderly, interleukin-6 plasma levels and the −174G>C polymorphism are associated with the development of cardiovascular disease
  publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology
  doi: 10.1161/01.ATV.0000040224.49362.60
– volume: 39
  start-page: 687
  year: 2004
  ident: 10.1016/j.jpsychires.2006.02.008_bib24
  article-title: Inflammatory mediators in the elderly
  publication-title: Experimental Gerontology
  doi: 10.1016/j.exger.2004.01.009
– volume: 61
  start-page: 194
  year: 2003
  ident: 10.1016/j.jpsychires.2006.02.008_bib20
  article-title: Adipose tissue as an endocrine organ: impact on insulin resistance
  publication-title: The Netherlands Journal of Medicine
– volume: 101
  start-page: 1767
  year: 2000
  ident: 10.1016/j.jpsychires.2006.02.008_bib37
  article-title: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
  publication-title: Circulation
  doi: 10.1161/01.CIR.101.15.1767
– volume: 36
  start-page: 768
  year: 2005
  ident: 10.1016/j.jpsychires.2006.02.008_bib17
  article-title: Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction
  publication-title: Stroke
  doi: 10.1161/01.STR.0000158915.28329.51
– volume: 542
  start-page: 991
  year: 2002
  ident: 10.1016/j.jpsychires.2006.02.008_bib32
  article-title: Interleukin-6 release from the human brain during prolonged exercise
  publication-title: The Journal of Physiology
  doi: 10.1113/jphysiol.2002.022285
– volume: 11
  start-page: 308
  issue: 2
  year: 2002
  ident: 10.1016/j.jpsychires.2006.02.008_bib9
  article-title: Peripheral inflammatory response in Alzheimer’s disease and multiinfarct dementia
  publication-title: Neurobiology of Disease
  doi: 10.1006/nbdi.2002.0556
– volume: 52
  start-page: M201
  year: 1997
  ident: 10.1016/j.jpsychires.2006.02.008_bib7
  article-title: The Association of plasma IL-6 levels with functional disability in community-dwelling elderly
  publication-title: Journals of Gerontology Series A-Biological Sciences and Medical Sciences
  doi: 10.1093/gerona/52A.4.M201
– volume: 20
  start-page: 2255
  year: 2000
  ident: 10.1016/j.jpsychires.2006.02.008_bib23
  article-title: Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study
  publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology
  doi: 10.1161/01.ATV.20.10.2255
– volume: 145
  start-page: 301
  year: 1997
  ident: 10.1016/j.jpsychires.2006.02.008_bib26
  article-title: Risk of dementia among persons with diabetes mellitus: a population-based cohort study
  publication-title: American Journal of Epidemiology
  doi: 10.1093/oxfordjournals.aje.a009106
– volume: 111
  start-page: 360
  year: 2005
  ident: 10.1016/j.jpsychires.2006.02.008_bib48
  article-title: IL-6: an early marker for outcome in acute ischemic stroke
  publication-title: Acta Neurologica Scandinavica
  doi: 10.1111/j.1600-0404.2005.00416.x
– volume: 110
  start-page: 124
  year: 2004
  ident: 10.1016/j.jpsychires.2006.02.008_bib47
  article-title: Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients
  publication-title: Acta Neurologica Scandinavica
  doi: 10.1111/j.1600-0404.2004.00286.x
– volume: 23
  start-page: 1255
  year: 2003
  ident: 10.1016/j.jpsychires.2006.02.008_bib28
  article-title: C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease. The PRIME Study
  publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology
  doi: 10.1161/01.ATV.0000079512.66448.1D
– volume: 86
  start-page: 7611
  year: 1989
  ident: 10.1016/j.jpsychires.2006.02.008_bib13
  article-title: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
  doi: 10.1073/pnas.86.19.7611
– volume: 86
  start-page: 7606
  year: 1989
  ident: 10.1016/j.jpsychires.2006.02.008_bib12
  article-title: Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells
  publication-title: Proceedings of the National Academy of Sciences of the United States of America
  doi: 10.1073/pnas.86.19.7606
– volume: 12
  start-page: 215
  issue: 3
  year: 1998
  ident: 10.1016/j.jpsychires.2006.02.008_bib25
  article-title: Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin
  publication-title: Alzheimer Disease and Associated Disorders
  doi: 10.1097/00002093-199809000-00016
– volume: 43
  start-page: 250
  year: 1993
  ident: 10.1016/j.jpsychires.2006.02.008_bib38
  article-title: Vascular dementia: diagnostic criteria for research study
  publication-title: Neurology
  doi: 10.1212/WNL.43.2.250
– volume: 13
  start-page: 106
  issue: 244
  year: 1998
  ident: 10.1016/j.jpsychires.2006.02.008_bib1
  article-title: Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer’s disease
  publication-title: Neuroscience Letters
  doi: 10.1016/S0304-3940(98)00136-0
– volume: 106
  start-page: 506
  year: 1999
  ident: 10.1016/j.jpsychires.2006.02.008_bib14
  article-title: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
  publication-title: The American Journal of Medicine
  doi: 10.1016/S0002-9343(99)00066-2
– volume: 103
  start-page: 97
  year: 2000
  ident: 10.1016/j.jpsychires.2006.02.008_bib27
  article-title: Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer’s disease: peripheral inflammation or signals from the brain?
  publication-title: Journal of Neuroimmunology
  doi: 10.1016/S0165-5728(99)00226-X
– volume: 10
  start-page: 134
  year: 2003
  ident: 10.1016/j.jpsychires.2006.02.008_bib6
  article-title: Neutralization of TRAIL death pathways protects human neuronal cell line from beta-amyloid toxicity
  publication-title: Cell Death and Differentiation
  doi: 10.1038/sj.cdd.4401143
– volume: 41
  start-page: 1886
  year: 1991
  ident: 10.1016/j.jpsychires.2006.02.008_bib11
  article-title: Prevalence of Alzheimer disease and other dementias in an elderly urban population: relationship with age, sex and education
  publication-title: Neurology
  doi: 10.1212/WNL.41.12.1886
– volume: 25
  start-page: 75
  year: 1995
  ident: 10.1016/j.jpsychires.2006.02.008_bib42
  article-title: Acute-phase proteins in osteoarthritis
  publication-title: Seminars in Arthritis and Rheumatism
  doi: 10.1016/S0049-0172(95)80020-4
– volume: 33
  start-page: 397
  year: 1999
  ident: 10.1016/j.jpsychires.2006.02.008_bib29
  article-title: Inflammatory markers in younger vs. elderly normal volunteers and in patients with Alzheimer’s disease
  publication-title: Journal of Psychiatric Research
  doi: 10.1016/S0022-3956(99)00016-3
– volume: 4
  start-page: 487
  issue: 8
  year: 2005
  ident: 10.1016/j.jpsychires.2006.02.008_bib36
  article-title: The age-dependent relation of blood pressure to cognitive function and dementia
  publication-title: Lancet Neurology
  doi: 10.1016/S1474-4422(05)70141-1
– volume: 299
  start-page: 536
  year: 2001
  ident: 10.1016/j.jpsychires.2006.02.008_bib2
  article-title: Intravenous human interleukin 1 impairs memory processing in mice: dependence on blood–brain barrier transport into posterior division of septum
  publication-title: Journal of Pharmacology and Experimental Therapeutics
  doi: 10.1016/S0022-3565(24)29260-0
– volume: 16
  start-page: 525
  year: 2002
  ident: 10.1016/j.jpsychires.2006.02.008_bib35
  article-title: Low levels of circulating inflammatory cytokines – Do they affect human brain functions?
  publication-title: Brain, Behavior, and Immunity
  doi: 10.1016/S0889-1591(02)00004-1
– volume: 181
  start-page: 201
  issue: 1
  year: 2005
  ident: 10.1016/j.jpsychires.2006.02.008_bib15
  article-title: Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2004.11.026
SSID ssj0007214
Score 2.3249586
Snippet Some cytokines have been involved in the pathogenesis of late onset Alzheimer’s disease (LOAD). A possible increase in plasma cytokines levels has been...
Abstract Some cytokines have been involved in the pathogenesis of late onset Alzheimer’s disease (LOAD). A possible increase in plasma cytokines levels has...
Some cytokines have been involved in the pathogenesis of late onset Alzheimer's disease (LOAD). A possible increase in plasma cytokines levels has been...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 686
SubjectTerms Adult and adolescent clinical studies
Aged
Aged, 80 and over
Alzheimer Disease - diagnosis
Alzheimer Disease - immunology
Alzheimer Disease - psychology
Alzheimer's disease
Biological and medical sciences
Cerebrovascular Disorders - diagnosis
Cerebrovascular Disorders - immunology
Cerebrovascular Disorders - psychology
Cytokines - blood
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Dementia, Vascular - diagnosis
Dementia, Vascular - immunology
Dementia, Vascular - psychology
Elderly people
Female
Humans
IL-1β
IL-6
Inflammation - diagnosis
Inflammation - immunology
Interleukin-10 - blood
Interleukin-1beta - blood
Interleukin-6 - blood
Late onset
Likelihood Functions
Logistic Models
Male
Medical sciences
Mental Status Schedule
Neurology
Organic mental disorders. Neuropsychology
Plasma citokynes
Proteins
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Reference Values
Risk Factors
TNF-α
Tumor Necrosis Factor-alpha - metabolism
Vascular dementia
Vascular diseases and vascular malformations of the nervous system
Title Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0022395606000525
https://www.clinicalkey.es/playcontent/1-s2.0-S0022395606000525
https://dx.doi.org/10.1016/j.jpsychires.2006.02.008
https://www.ncbi.nlm.nih.gov/pubmed/16600299
https://www.proquest.com/docview/57226174
https://www.proquest.com/docview/70341616
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier ScienceDirect Freedom Collection Journals
  customDbUrl:
  eissn: 1879-1379
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007214
  issn: 0022-3956
  databaseCode: ACRLP
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier ScienceDirect Journals
  customDbUrl:
  eissn: 1879-1379
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007214
  issn: 0022-3956
  databaseCode: AIKHN
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1879-1379
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007214
  issn: 0022-3956
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1879-1379
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007214
  issn: 0022-3956
  databaseCode: AKRWK
  dateStart: 19630101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Li9RAEC6WFUQQ8e34GPvgNW6SfiTB07C4jMouHlzYW9NJujG7s8kwyRz0IP4N_56_xKqkM8OiAwNeQ1ce3ZXqr7q-qgJ4YwrFlctcEDp0UYQSLsgRNgeZ48ImuXSKU6Lw6Zman4uPF_LiAI7HXBiiVXrbP9j03lr7K0d-No-WVUU5vri1EbxXfbyKEs2p-hfq9NsfW5oHejhiUzEcR3s2z8DxuhwoxejY-rAEVe9Md21Rd5emxYlzQ8eL3ZC035pO7sM9jynZbHjtB3Bg64dw-9RHzR-B_YwQ-dqw4lvXXBHNnflO3ayqWUNtulm7zulApmV0LssWCEAZ0aw7Nlt8_2qra7v6_fNXy3w4hzUrNlJYWdkfMFbmMZyfvP9yPA98e4WgQNjUUWnITEoTGU41y2yZKmclDy2nDsRlLEuFKyVcnvBEZEblhRVpyctMULYWyvEncFg3tX0GrECYGRaZCY2QIjY8LSPnRJlHMgmN5HYCyTijuvC1x6kFxkKPJLNLvV0Lao2pdBhrXIsJRBvJ5VB_Yw-ZbFw0PeaXokXUuEnsIZv8S9a2_tdudaRbHKn_Ur8JvNtI3tDgPZ87vaFd249NFTpBMQ54PaqbRgtAYR1T22bdapnEVFZf7B6BVp38WDWBp4Oebu-u-rhs9vy_Xv4F3OmPvHuO40s47FZr-wqxWpdP-59xCrdmHz7Nz_4ACBlBgA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NattAEF5SB9pCCf2PmzbZQ68ikvZHEj2ZkOA0sekhgdyWlbRLlTqSseRDeupr9PX6JJ2RVjYhNRh6NTu2vDOa_WbnmxlCPutMMmkT6_kWQhQuufVSgM1eYhk3USqsZFgoPJnK8TX_eiNudshJXwuDtErn-zuf3npr98mx283jeVFgjS8cbQjvZZuvEk_ILhfgkwdkd3R-MZ6uHDIEOXzVNBwEHKGno3nddqxiiG1dZgIbeMabTqkXc13D3tlu6MVmVNqeTmcvyZ6DlXTUPfkrsmPK1-TpxCXO3xDzDVDynabZfVP9QKY7dcO6aVHSCid103qZ4p1MTfFqls4Ag1JkWjd0NPv53RR3ZvHn1--auowOrRa0Z7HSvL1jLPRbcn12enUy9tyEBS8D5NRgd8hECB1ohm3LTB5LawTzDcMhxHkocgnK4jaNWMQTLdPM8DhnecKxYAvk2DsyKKvS7BOaAdL0s0T7GpQQahbngbU8TwMR-VowMyRRv6Mqc-3HcQrGTPU8s1u11gVOx5TKDxXoYkiCleS8a8GxhUzSK031JabgFBWcE1vIRv-SNbV7u2sVqBpWqkcWOCRfVpIPjHjL3z18YF3rPxtLiINCWHDUm5sCJ4CZHV2aalkrEYXYWZ9vXgGOHUNZOSTvOztdf7tsU7PJh_96-CPybHw1uVSX59OLA_K8vQFvKY8fyaBZLM0ngG5Neuhezb_LU0Qr
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+cytokines+profile+in+older+subjects+with+late+onset+Alzheimer%E2%80%99s+disease+or+vascular+dementia&rft.jtitle=Journal+of+psychiatric+research&rft.au=Zuliani%2C+G.&rft.au=Ranzini%2C+M.&rft.au=Guerra%2C+G.&rft.au=Rossi%2C+L.&rft.date=2007-10-01&rft.pub=Elsevier+Ltd&rft.issn=0022-3956&rft.volume=41&rft.issue=8&rft.spage=686&rft.epage=693&rft_id=info:doi/10.1016%2Fj.jpsychires.2006.02.008&rft.externalDocID=S0022395606000525
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00223956%2FS0022395607X0195X%2Fcov150h.gif